Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Whitehawk Therapeutics, Inc. (WHWK) had Return on Investments of -9.10% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-16.64M |
|
-- |
|
-- |
|
$18.11M |
|
$-18.11M |
|
$1.47M |
|
$-16.64M |
|
$-16.64M |
|
$-16.64M |
|
$-16.64M |
|
$-16.64M |
|
$-16.64M |
|
$-18.11M |
|
$-18.47M |
|
82.89M |
|
82.89M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$192.41M |
|
$0.00M |
|
$1.58M |
|
$193.99M |
|
$11.07M |
|
-- |
|
-- |
|
$11.07M |
|
$182.93M |
|
$182.93M |
|
$182.93M |
|
57.01M |
|
| Cash Flow Statement Financials | |
$-36.74M |
|
$2.56M |
|
$81.84M |
|
$37.57M |
|
$85.23M |
|
$47.67M |
|
$3.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.10% |
|
-9.10% |
|
-8.58% |
|
|
Return on Investments |
-9.10% |
$3.21 |
|
$-0.44 |
|
$-0.44 |
|